Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).
D001772:Blood Cell Count; D001792:Blood Platelets / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D003561:Cytarabine / Q000008:administration & dosage*; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D012156:Reticulocytes / Q000187:drug effects
D003561:Cytarabine